Русский

Pharmaceutical Industry Information Portal

HomeNews

News

World Pharma News

AbbVie ends collaboration with BioArctic on alpha-synuclein portfolio

Techno -
BioArctic AB (publ) has announced that the company's partner AbbVie has decided to terminate its collaboration with BioArctic regarding the portfolio of alpha-synuclein antibodies,...
Regulatory News

FDA postpones approval of Teva’s schizophrenia drug

Techno -
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration (“FDA”) has issued a...
World Pharma News

BioXcel Therapeutics raises funding from Oaktree Capital, Qatar’s Investment Authority

Techno -
BioXcel Therapeutics, Inc., a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,  April 19th announced strategic financing...
World Pharma News

J&J settles West Virginia opioid lawsuit for $99 million

Techno -
Johnson & Johnson said on Monday it agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid...
World Pharma News

Halozyme to acquire Antares Pharma in a $960 million deal

Techno -
Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares...
World Pharma News

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

Techno -
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...
1...313233...113Page 32 of 113
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories